<!doctype html><html><head><meta charset=utf-8><title>Less MS (MRI) decline after raising Vitamin D levels – clinical trial</title>
<link rel=stylesheet href="/css/main.css?v=1751038173"><link rel=stylesheet href="/css/pagination.css?v=1751038173"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1751038173"></script><script src="/js/search.js?v=1751038173"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Less MS (MRI) decline after raising Vitamin D levels – clinical trial</h1><time>October 31, 2012</time><div data-pagefind-body><h4 id=vitamin-d-and-multiple-sclerosis-an-interview-with-ellen-mowryhttpwwwnews-medicalnetnews20121031vitamin-d-and-multiple-sclerosis-an-interview-with-ellen-mowryaspx-news-medicalnet><a href=http://www.news-medical.net/news/20121031/Vitamin-D-and-multiple-sclerosis-an-interview-with-Ellen-Mowry.aspx>Vitamin D and multiple sclerosis: an interview with Ellen Mowry</a> news Medical.Net</h4><p><strong>Excellent interview</strong></p><p><strong>Highlights</strong></p><ul><li><p>Tracked 469 people with MS for 5 years</p></li><li><p>Higher vitamin D was associated with fewer MS spots on MRI the next year.</p></li></ul><h4 id=vitamin-d-status-predicts-new-brain-magnetic-resonance-imaging-activity-in-multiple-sclerosis>Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.</h4><p>Ann Neurol. 2012 Aug;72(2):234-40. <a href=https://doi.org/10.1002/ana.23591.>doi: 10.1002/ana.23591.</a></p><p>Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D.</p><p>Multiple Sclerosis Center, Department of Neurology, University of California at San Francisco, San Francisco, CA, USA. <a href=mailto:emowry1@jhmi.edu>emowry1@jhmi.edu</a></p><p>OBJECTIVE:</p><p>We sought to determine whether vitamin D status is associated with developing new T2 lesions or contrast-enhancing lesions on brain magnetic resonance imaging (MRI) in relapsing multiple sclerosis (MS).</p><p>METHODS:</p><p>EPIC is a 5-year longitudinal MS cohort study at the University of California at San Francisco. Participants had clinical evaluations, brain MRI, and blood draws annually. From the overall cohort, we evaluated patients with clinically isolated syndrome or relapsing-remitting MS at baseline. In univariate and multivariate (adjusted for age, sex, ethnicity, smoking, and MS treatments) repeated measures analyses, annual 25-hydroxyvitamin D levels were evaluated for their association with subsequent new T2-weighted and gadolinium-enhancing T1-weighted lesions on brain MRI, clinical relapses, and disability (Expanded Disability Status Scale <span>[EDSS]</span>).</p><p>RESULTS:</p><p>A total of 2,362 3T brain MRI scans were acquired from 469 subjects. In multivariate analyses, <strong>each 10 ng/ml higher 25-hydroxyvitamin D level was associated with a 15% lower risk of a new T2 lesion</strong> (incidence rate ratio <span>[IRR]</span>, 0.85; 95% confidence interval <span>[CI]</span>, 0.76-0.95; p = 0.004) and a <strong>32% lower risk of a gadolinium-enhancing lesion</strong> (IRR, 0.68; 95% CI, 0.53-0.87; p = 0.002). Each 10 ng/ml higher vitamin D level was associated with lower subsequent disability (-0.047; 95% CI, -0.091 to -0.003; p = 0.037). Higher vitamin D levels were associated with lower, but not statistically significant, relapse risk. Except for the EDSS model, all associations were stronger when the within-person change in vitamin D level was the predictor.</p><p>INTERPRETATION:</p><p>Vitamin D levels are inversely associated with MS activity on brain MRI.</p><p>These results provide further support for a randomized trial of vitamin D supplementation.</p><p>Copyright © 2012 American Neurological Association.</p><p>PMID: 22926855</p></div><hr class=tag-separator><div class=tags><span>Tags: </span><span class=tag>autoimmune</span>
<span class=tag>blood levels</span>
<span class=tag>brain</span>
<span class=tag>cognitive</span>
<span class=tag>health risk</span>
<span class=tag>high dose</span>
<span class=tag>intervention</span>
<span class=tag>multiple sclerosis</span>
<span class=tag>Multiple Sclerosis</span>
<span class=tag>smoking</span>
<span class=tag>therapeutic intervention</span>
<span class=tag>vitamin d</span>
<span class=tag>vitamin d blood test</span></div><div data-pagefind-meta=tags hidden>autoimmune, blood levels, brain, cognitive, health risk, high dose, intervention, multiple sclerosis, Multiple Sclerosis, smoking, therapeutic intervention, vitamin d, vitamin d blood test</div></article></div></div><script src="/js/lightspa.js?v=1751038173"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1751038173",indexUrl:"/search/search_index.json.gz?v=1751038173"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1751038173"></script><script src="/js/tiki-redirects.js?v=1751038173"></script></body></html>